1. An electroporation platform for Erlotinib resistance screening in living non-small cell lung cancer (NSCLC) cells. (10th January 2018) Authors: Yan, Z; Hui, T H; Fong, H W; Shao, X; Cho, W C; Ngan, K C; Yip, T C; Lin, Y Journal: Biomedical physics & engineering express Issue: Volume 4:Number 2(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗